← All stocks

OnKure Therapeutics, Inc.

OKUR Net selling
CIK 0001637715 #4079 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$5.50K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$5.50K
8 of 8 sales
Net
−$5.50K
−$5.50K against sales at will

By person

8 insiders · 8 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Leverone Jason A.
Chief Financial Officer
$4.27K (4)
−$4.27K
18,802
$82.66K
+164.6%
Saccomano Nicholas A
President and CEO
$1.22K (4)
−$1.22K
11,247
$49.45K
+40.6%
ACORN BIOVENTURES, L.P.
10% owner
2,839,674
$12.48M
+97.2%
Leonard Braden Michael
Former 10% owner of RPHM
447,815
$1.97M
Manke Isaac
Director
20,583
$90.49K
Mathers Edward T
Director
15,310
$67.31K
Carruthers R Michael
Director
4,939
$21.71K
Cormorant Asset Management, LP entity
Former 10% Owner
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 3.0 over the window, from 13,673,565 to 40,496,309 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 34
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 18,839
History held since 12 Apr 2021